$204.02
1.09% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US46266C1053
Symbol
IQV

IQVIA Stock price

$204.02
-10.61 4.94% 1M
-25.58 11.14% 6M
-27.36 11.82% YTD
-6.71 3.18% 1Y
-61.34 23.12% 3Y
+57.53 39.27% 5Y
+146.27 253.28% 10Y
NYSE, Closing price Mon, Nov 25 2024
+2.20 1.09%
ISIN
US46266C1053
Symbol
IQV
Sector

Key metrics

Market capitalization $37.03b
Enterprise Value $49.02b
P/E (TTM) P/E ratio 26.76
EV/FCF (TTM) EV/FCF 25.00
EV/Sales (TTM) EV/Sales 3.20
P/S ratio (TTM) P/S ratio 2.42
P/B ratio (TTM) P/B ratio 5.32
Revenue growth (TTM) Revenue growth 3.17%
Revenue (TTM) Revenue $15.31b
EBIT (operating result TTM) EBIT $2.16b
Free Cash Flow (TTM) Free Cash Flow $1.96b
Cash position $1.71b
EPS (TTM) EPS $7.62
P/E forward 28.62
P/S forward 2.41
EV/Sales forward 3.19
Short interest 1.65%
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a IQVIA forecast:

20x Buy
80%
5x Hold
20%

Analyst Opinions

25 Analysts have issued a IQVIA forecast:

Buy
80%
Hold
20%

Financial data from IQVIA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
15,314 15,314
3% 3%
100%
- Direct Costs 11,055 11,055
2% 2%
72%
4,259 4,259
6% 6%
28%
- Selling and Administrative Expenses 968 968
6% 6%
6%
- Research and Development Expense - -
-
-
3,291 3,291
7% 7%
21%
- Depreciation and Amortization 1,127 1,127
3% 3%
7%
EBIT (Operating Income) EBIT 2,164 2,164
13% 13%
14%
Net Profit 1,405 1,405
26% 26%
9%

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Neutral
Business Wire
20 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS Healthcare Conference in Rancho Palos Verdes, California on Wednesday, November 13, 2024 at 1:15 p.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations ...
Neutral
Seeking Alpha
26 days ago
IQVIA Holdings Inc. (NYSE:IQV ) Q3 2024 Results Conference Call October 31, 2024 9:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations & Treasury Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President and Chief Financial Officer Eric Sherbet - Executive Vice President and General Counsel Mike Fedock - Senior Vice President,...
Negative
Reuters
26 days ago
Contract research firm IQVIA lowered its annual revenue forecast on Thursday, due to delays in two clinical trials as one of its clients faces logistical challenges.
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 87,000
Founded 1950
Website www.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today